Financhill
Back

Poseida Therapeutics Stock Predictions

Poseida Therapeutics Stock Forecast

  • Is Poseida Therapeutics Stock Undervalued?
    The current Poseida Therapeutics [PSTX] share price is $2.76. The Score for PSTX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • PSTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Poseida Therapeutics Stock Go Up Next Year?

Data Unavailable

Poseida Therapeutics Stock Rating

Data Unavailable

Poseida Therapeutics Stock Price History

Is PSTX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PSTX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
poseida.com

52-Week Data

52-Week High:
4.27
52-Week Low:
1.87

Prediction Charts

Market Cap:
269M
Price in USD:
2.76
Volume:
699.88K
Beta:
0.54

Technical Analysis

SMA50:
2.81
SMA100:
2.95
SMA200:
2.98
52-Wk Change:
24.89%

Stock Predictions

  • Is Poseida Therapeutics stock public?
    Yes, Poseida Therapeutics is a publicly traded company.
  • What is the Poseida Therapeutics stock quote today?
    The Poseida Therapeutics stock price is 2.76 USD today.
  • How to buy Poseida Therapeutics stock online?
    You can buy Poseida Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-29 2.48 2.45 2.49 2.38
Oct-30 2.45 2.39 2.48 2.38
Oct-31 2.39 2.36 2.39 2.32
Nov-1 2.40 2.47 2.48 2.39
Nov-4 2.43 2.54 2.61 2.43
Nov-5 2.50 2.66 2.66 2.48
Nov-6 2.70 2.78 2.86 2.60
Nov-7 2.80 2.93 3.02 2.80
Nov-8 3.25 3.08 3.58 3.02
Nov-11 3.10 3.70 3.70 3.09
Nov-12 3.68 3.69 3.84 3.46
Nov-13 3.75 3.27 3.78 3.26
Nov-14 3.33 3.21 3.36 3.09
Nov-15 3.27 2.76 3.28 2.73

Poseida Therapeutics Earnings

Data Unavailable

Poseida Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and a decrease next year of $1.08 per share.

* Poseida Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.